About.com Health

Share this article:
Company Profile
Silver Medal Winner for “Health Website of the Year” at the 2007 MM&M Awards, About.com Health is among the top health Web sites with more than 8 million visitors each month. About.com Health has the highest composition of women 25-54 and is the leader in many categories, like Arthritis, Pediatrics and Diet & Nutrition. (Source:Nielsen//NetRatings July 2007/@plan Summer 2007)

About.com is one the 15 most visited sites in the U.S. Each month, over 36 million unique visitors in the U.S. and 50 million worldwide trust About.com and its expert "Guides" to help them make more informed decisions on topics ranging from health, food, parenting and technology. Content on About.com is written by over 600 expert "Guides" who share their passions, expertise and how-to information in almost two million pieces of original content. This passion translates into reach. No other content site reaches more moms than About.com. We also reach more teens than MTV, more women than iVillage andmore men than ESPN. (Source: Nielsen//NetRatings July 2007)

Services and Offerings
Interactive opportunities include targeted media in over 600 categories, sponsorships, custom sites, promotions, mobile and podcasting.

If there is a way to reach a targeted consumer, About.com helps advertisers deliver those messages regardless of platform. Plus, our bedside manner is more like a visit from the family doctor, rather than a medical encyclopedia.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

Lilly Q1 sales dip

Lilly Q1 sales dip

US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...